Scalp hair and blood sera of two groups of psoriatic individuals were examined regarding some of their mineral contents by flame photometric and colorimetric procedures, and the findings compared with a normal control group. The result obtained revealed changes in the mineral content of scalp hair of psoriatics. A possible relationship may exist between hair and serum minerals.

Download full-text PDF

Source

Publication Analysis

Top Keywords

scalp hair
12
hair blood
8
blood sera
8
study minerals
4
minerals scalp
4
hair
4
sera psoriatics
4
psoriatics scalp
4
sera groups
4
groups psoriatic
4

Similar Publications

Background: Intralesional (IL) steroids are the first-line treatment option for localized alopecia areata (AA). The present study aimed to compare the efficacy of topical calcipotriol with IL triamcinolone acetonide versus IL triamcinolone acetonide alone in AA.

Methods: This randomized single-blinded clinical trial was conducted in a dermatology outpatient department.

View Article and Find Full Text PDF
Article Synopsis
  • Alopecia areata (AA) is a non-scarring hair loss condition, often seen in children with atopic dermatitis (AD), and its exact cause remains unclear.
  • A case study of a child with myasthenia gravis showed severe AA and moderate AD, which improved significantly after a year of treatment with baricitinib and corticosteroid ointment, with a notable drop in severity scores and visible hair regrowth.
  • The study highlights the potential of Janus kinase inhibitors in treating pediatric AA and AD, emphasizing the safety and lack of significant adverse effects during the treatment, except for mild folliculitis.
View Article and Find Full Text PDF

Androgenic alopecia (AGA), the most prevalent type of progressive hair loss, currently lacks an effective topical treatment regimen. In this study, we synthesized an ionic liquid (IL) to co-solubilize minoxidil (MXD) and finasteride (FIN) and subsequently formulated them into an in situ thermosensitive ionic liquid/cyclodextrin/poloxamer hydrogel (ICPG), termed M + F@ICPG. M + F@ICPG was developed for the transdermal co-delivery of these two drugs, aiming to provide a multipath therapeutic approach for AGA while avoiding the adverse effects commonly associated with oral FIN and topical MXD tincture.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!